Tender Details

Country: USA
Summary: Online recruitment campaign for an influenza virus seasonal epidemic and pandemic Phase 1 study
UST Ref No: 112358578
Deadline: 03 Jan 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: NOI-NIAID-25-2251388
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Description
PRE-SOLICITATION NOTICE - NOTICE OF INTENT TO SOLE SOURCE
NOI-NIAID-25-2251388
NAICS - 541810, Advertising Agencies

This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with BuildClinical, LLC of New York, NY to procure an online recruitment campaign for an influenza virus seasonal epidemic and pandemic Phase 1 open-label, dose escalation study to evaluate the dose, safety, tolerability, and immunogenicity of mosaic hexavalent influenza vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) with and without Army Liposome Formulation containing saponin QS-21 (ALFQ) adjuvant.
NIAID conducts many clinical trials at the NIH Clinical Center, America-s research hospital, which is located on the main campus in Bethesda, Maryland. NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world. NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. Influenza virus causes seasonal epidemics and pandemics at irregular intervals that result in significant morbidity and mortality. According to the World Health Organization (WHO) the annual epidemics result in 3 to 5 million cases of severe illness and about 290,000 to 650,000 respiratory deaths. The Center for Disease Control (CDC) estimates that during the 2019-2020 influenza season, there were 56 million illnesses, 26 million medical visits, 740,000 hospitalizations, and 62,000 deaths in the United States (US). Despite the annual i...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Online recruitment campaign for an influenza virus seasonal epidemic and pandemic Phase 1 study - USA Tender

The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Online recruitment campaign for an influenza virus seasonal epidemic and pandemic Phase 1 study. This tender is published on USARFP under UST Ref No: 112358578 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-01-03.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.